β-defensin 110, a member of the defensin family of antimicrobial peptides, plays a crucial role in the innate immune system's defense against a wide range of pathogens, including bacteria, fungi, and viruses. These peptides are known for their ability to penetrate and disrupt the microbial cell membrane, leading to pathogen death. This mechanism is primarily based on the cationic and amphipathic properties of defensins, which allow them to interact with and compromise the integrity of the negatively charged microbial membranes. Beyond their direct antimicrobial activity, β-defensins also participate in modulating the immune response, acting as a bridge between innate and adaptive immunity by attracting immune cells to the site of infection and promoting the activation of these cells. The multifunctionality of β-defensin 110 underscores its significance in maintaining host defense and immunoregulation.
The inhibition of β-defensin 110 can arise through various mechanisms, reflecting a countermeasure by pathogens to evade the host's immune defenses or as a result of regulatory processes within the host aimed at controlling inflammation and preventing tissue damage. Pathogens have evolved strategies to neutralize defensins, including the production of proteases that degrade these peptides or the expression of surface molecules that reduce defensin-mediated membrane disruption. From the host perspective, the regulation of β-defensin 110 expression and activity is tightly controlled to prevent excessive inflammation that can lead to tissue damage. Regulatory mechanisms may include the modulation of signaling pathways that influence defensin gene expression, such as downregulation of NF-κB activity, or alterations in the epigenetic landscape that affect the accessibility of defensin genes for transcription. Additionally, the host may produce proteins that bind to and sequester defensins, reducing their availability to act against pathogens. These regulatory and inhibitory mechanisms ensure a balanced immune response, enabling effective defense against pathogens while minimizing potential damage to the host's own tissues through excessive or prolonged inflammatory responses.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $76.00 $82.00 $367.00 | 36 | |
A glucocorticoid that can suppress the expression of various β-defensins by modulating inflammatory pathways. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $62.00 $90.00 $299.00 $475.00 $1015.00 $2099.00 | 69 | |
An immunosuppressant that inhibits calcineurin, potentially leading to decreased defensin expression. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $56.00 $260.00 $980.00 | 163 | |
A proteasome inhibitor that affects NF-kB signaling, which can influence β-defensin expression. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
An ERK pathway inhibitor which may modulate the signaling pathways that influence β-defensin expression. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
Inhibits p38 MAPK, a pathway known to regulate β-defensin expression. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $65.00 $267.00 | 257 | |
A JNK inhibitor that can modulate cellular stress responses, potentially influencing β-defensin expression. | ||||||
Chelerythrine | 34316-15-9 | sc-507380 | 100 mg | $540.00 | ||
A protein kinase C (PKC) inhibitor. PKC pathways can influence β-defensin expression. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
Inhibits PI3K, which is involved in various cellular signaling pathways that can potentially modulate β-defensin expression. | ||||||
Gossypol | 303-45-7 | sc-200501 sc-200501A | 25 mg 100 mg | $114.00 $225.00 | 12 | |
An inhibitor of Bcl-2, which can influence apoptosis and potentially alter β-defensin environments. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Another PI3K inhibitor, modulating pathways that might influence β-defensin expression. |